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Neisseria gonorrhea, Mycoplasma genitalium and Trichomonas vaginalis 
using self-collected rectal and pharyngeal swabs, and urine samples. 
PCR-based APTIMA® STI-assays were used. We collected information 
on sociodemographics, HIV-status, clinical symptoms, sexual behaviour 
and PrEP-use. We calculated prevalence ratios (PR) to identify risk factors 
and stratified for HIV-status and PrEP-use.
Results: 
As of 22/04/2018, 1,199 MSM were included: 50.4% (603/1,199) were 
HIV-positive, median age was 39 years [range 18-71]. Overall STI positivity 
was 31.4% (Mycoplasma genitalium=17.8%, Neisseria gonorrhea=9.9%, 
Chlamydia trachomatis=9.1%, Trichomonas vaginalis=0.1%) and was not 
significantly higher in HIV-positive participants (PR=1.0;CI95%=0.8-1.1). 
66.3% (230/347) of STI-positive participants did not report STI-related 
symptoms. 30.1% (162/539) of HIV-negative participants currently took 
PrEP. In PrEP-users, the number of male sexual partners (median 12 vs. 5; 
p<0.05), sex without condom (91.7% vs 65.9%;p<0.05), use of party drugs 
such as liquid ecstasy (42.8% vs. 26.6%;p<0.05) within last 6 months 
and STI positivity (PR=1.8;CI95%=1.4-2.3) were significantly higher.
Conclusions : A high proportion of mainly asymptomatic MSM are positive 
for STI in Germany. Health insurance covered regular STI screenings of 
PrEP-users amongst MSM, independent of symptoms, would facilitate 
early treatment and thereby reduce further spread.
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Background:
NGS techniques, allow a much deeper genetic analysis of influenza 
viruses, compared to traditional Sanger sequencing of hemagglutinin 
gene. The present study aims to perform phylogenetic and mutational 
analysis at whole-genome level in order to search for genetic features 
related to vaccine failure.
Methods:
Nasopharyngeal swabs were collected during 2016/17 and 2017/18 winter 
seasons, from ILI patients participating in EuroEVA/I-MOVE study. Whole 
genome sequences were obtained for 179 influenza A(H3) viruses by NGS 
in a MiSeq platform and subsequent bioinformatics analysis using the 
web-based platform INSaFLU (https://insaflu.insa.pt/). Additional fine-
tune sequence analysis was performed using MEGA-7.
Results:
All sequenced viruses clustered in 2 HA-based genetic groups: 58 
(32.4%) in 3C.2a group and 121 (67.6%) in 3C.2a1. Vaccine failure cases 
were detected in a higher proportion in 3C.2a1 group (20/121, 16.5%) 
than in 3C.2a (8/58, 13.8%). WGS analysis further revealed intra-subtype 
reassortments based on the closest genetic relatedness of each viral 
segment to the representative virus of seasonal A(H3) genetic (sub-)
groups, with viruses being distributed in 6 different patterns of genome 
constellation. The group with all genomic segments most closely related 
to A/Singapore/INFIMH-16-0019/2016 harboured a higher number 
of vaccine failure cases (14/69, 20.3%). Despite 16 viruses (from 28 
detected in vaccinated cases) presented amino acid substitutions not 
found in unvaccinated cases, these substitutions revealed a sporadic 
pattern.
Conclusions:
Vaccine failure cases were not exclusive of any genetic group or 
reassortment pattern, although they were found in slightly higher 
proportion among 3C.2a1 viruses and in viruses with all genetic segments 
mostly similar to A/Singapore/INFIMH-16-0019/2016. The further use 
of WGS in flu surveillance is essential to better understand genetic 
determinants of infection and evolutionary dynamics of influenza virus.
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